ProAssurance

PRA

Market cap $1.27B

ProAssurance (PRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock?

Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.

Does ProAssurance (PRA) have what it takes to be a top stock pick for momentum investors? Let's find out.

PRA posts Q4 EPS of 82 cents, topping estimates as expenses fall and investment income rises despite lower premiums.

While the top- and bottom-line numbers for ProAssurance (PRA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ProAssurance (PRA) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.36 per share a year ago.

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $33.4 million, or $0.64 per diluted share, and operating income(1) of $42.4 million, or $0.82 per diluted share, for the three months ended December 31, 2025. For the year ended December 31, 2025, net income was $50.9 million, or $0.99 per diluted share, and operating income was $83.9 million, or $.

PRA misses Q3 EPS estimates as weak Specialty P&C results and higher costs outweigh gains in investment income.

The headline numbers for ProAssurance (PRA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.